论文部分内容阅读
目的 探讨米非司酮对排卵型月经过多和子宫内膜脱卸不全的临床治疗效果。方法 诊断性刮宫明确病理诊断后或撤血性月经周期的第 2 0天起 ,每日口服米非司酮 10mg ,连用 5天 ,治疗 3个月后随访 3个月 ,观察患者的月经周期、经期和经量变化。结果 96例排卵型月经过多患者治疗期间 ,88例经量明显减少 ( 91 67% ) ,83例治疗后疗效得以维持 ( 86 46% /94 3 2 % )。 13 1例子宫内膜脱卸不全者治疗后经期由 10 6± 2 3天减少至 5 8± 2 2天 ,随访期间的月经期为 6 1± 2 3天。结论 米非司酮是治疗排卵型月经过多和子宫内膜脱卸不全的有效药物。
Objective To investigate the clinical effect of mifepristone on ovulation menorrhagia and endometrial detachment. Methods Diagnostic curettage clear pathology diagnosis or withdrawal menstrual cycle on the 20th day, the daily oral mifepristone 10mg, once every 5 days, 3 months after treatment for 3 months, observe the patient’s menstrual cycle, menstrual period And by the amount of change. Results During the treatment of 96 cases of ovulatory menorrhagia, the volume of 88 patients decreased significantly (91 67%) and the efficacy of 83 patients (86 46% / 94 3 2%) was maintained. Thirteen cases of endometrial dysplasia after treatment decreased from 10 6 ± 23 days to 58 ± 22 days, followed up during the menstrual period of 61 ± 23 days. Conclusion Mifepristone is an effective drug for treating ovulatory menorrhagia and endometrial dysplasia.